NCT06714812View on ClinicalTrials.gov

Diarrheal Adverse Events in Caucasian Patients With Idiopathic Pulmonary Fibrosis Undergoing Treatment With Nintedanib

Active, not recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

August 20, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

October 31, 2025

Conditions

IPF

Trial Locations (1)

40138

IRCCS Azienda Ospedaliera-Universitaria di Bologna, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT06714812 - Diarrheal Adverse Events in Caucasian Patients With Idiopathic Pulmonary Fibrosis Undergoing Treatment With Nintedanib | Biotech Hunter | Biotech Hunter